UMIN-ICDS Clinical Trial
| Unique ID issued by UMIN | UMIN000060930 |
|---|---|
| Receipt number | R000069728 |
| Scientific Title | Deprescribing in Frail Patients Using the STOPPFrail Criteria: A Scoping Review |
| Date of disclosure of the study information | 2026/03/13 |
| Last modified on | 2026/03/13 17:38:53 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Deprescribing in Frail Patients Using the STOPPFrail Criteria: A Scoping Review
Acronym
Deprescribing in Frail Patients Using the STOPPFrail Criteria: A Scoping Review
Scientific Title
Deprescribing in Frail Patients Using the STOPPFrail Criteria: A Scoping Review
Scientific Title:Acronym
Deprescribing in Frail Patients Using the STOPPFrail Criteria: A Scoping Review
Region
| Japan |
Condition
Condition
Patients with limited life expectancy and frailty, irrespective of specific diseases.
Classification by specialty
| Medicine in general | Geriatrics | Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To investigate the impact of polypharmacy on QOL in frail older adults with limited life expectancy.
Basic objectives2
Others
Basic objectives -Others
To examine whether deprescribing interventions based on the STOPPFrail criteria improve patient's QOL.
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
QOL
Key secondary outcomes
Base
Study type
Others,meta-analysis etc
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| 120 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
The inclusion criteria were studies involving adult hospitalised patients with frailty. Only original research articles were included. No restriction was placed on the year of publication, and studies published in Japanese or English were eligible. Eligible studies were required to report clinical outcomes such as patients' quality of life (QOL), changes in the number of prescribed medications, discontinuation rates of potentially unnecessary medications, and the incidence of adverse events.
Key exclusion criteria
The exclusion criteria were review articles and studies that did not involve adult patients.
Target sample size
Research contact person
Name of lead principal investigator
| 1st name | Takenori |
| Middle name | |
| Last name | Ichimura |
Organization
Tokyo University of Pharmacy and Life Sciences
Division name
Center for Experimental Pharmacy Practice, School of Pharmacy
Zip code
192-0392
Address
1432-1, Horinouchi, Hachioji, Tokyo, Japan
TEL
042-676-5111
ichimura@toyaku.ac.jp
Public contact
Name of contact person
| 1st name | Takenori |
| Middle name | |
| Last name | Ichimura |
Organization
Tokyo University of Pharmacy and Life Sciences
Division name
Center for Experimental Pharmacy Practice, School of Pharmacy
Zip code
192-0392
Address
1432-1, Horinouchi, Hachioji, Tokyo, Japan
TEL
042-676-5111
Homepage URL
ichimura@toyaku.ac.jp
Sponsor or person
Institute
Tokyo University of Pharmacy and Life Sciences
Institute
Department
Personal name
Funding Source
Organization
Tokyo University of Pharmacy and Life Sciences
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Tokyo University of Pharmacy and Life Sciences
Address
1432-1, Horinouchi, Hachioji, Tokyo, Japan
Tel
042-676-5189
ichimura@toyaku.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2026 | Year | 03 | Month | 13 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
0
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2026 | Year | 03 | Month | 13 | Day |
Date of IRB
| 2026 | Year | 03 | Month | 13 | Day |
Anticipated trial start date
| 2026 | Year | 03 | Month | 13 | Day |
Last follow-up date
| 2026 | Year | 03 | Month | 13 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
For this topic, literature will be searched and extracted using Ichushi-Web, PubMed, and CENTRAL, and the findings will be synthesized to derive implications for future research.
Management information
Registered date
| 2026 | Year | 03 | Month | 13 | Day |
Last modified on
| 2026 | Year | 03 | Month | 13 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000069728
